Metaplastic carcinoma of the breast-analysis of eight Asian patients with special emphasis on two unusual cases presenting with inflammatory-type breast cancer
Journal
Anticancer Research
Journal Volume
20
Journal Issue
3 B
Pages
2219-2222
Date Issued
2000
Author(s)
Abstract
Metaplastic carcinoma of the breast is a rare form of breast cancer and has an uncertain prognostic significance. Cases from Asian countries have never been reported in the English literature. Between 1983 and 1998, we encountered 8 cases in our institution. There were 7 women and one man with a median age of 52.5 (37-73) years. Pathologic diagnosis included three poorly-differentiated adenosquamous carcinomas, two adenocarcinomas with spindle cell metaplasia, two matrix-producing carcinomas and one carcinosarcoma. Estrogen receptor was positive in 2 (25%) patients. Local recurrence or distant metastasis developed in 3 patients within one year of initial treatment. With a mean follow-up of 81 months (range, 19-183 months), 5 patients were disease-free at the time of this report. Interestingly, two of our patients had presented with huge-sized inflammatory breast cancer and were refractory to neo-adjuvant chemotherapy, but enjoyed an unexpected long disease-free survival after mastectomy. Although the clinical course of our patients appeared in general similar to that of the Western series, the two patients with inflammatory breast carcinoma ran a very unusual course, which may deserve further characterization.
SDGs
Other Subjects
cyclophosphamide; epirubicin; estrogen receptor; fluorouracil; adenosquamous carcinoma; adult; aged; article; Asian; breast adenocarcinoma; breast carcinoma; cancer recurrence; carcinosarcoma; clinical article; female; follow up; human; inflammation; male; mastectomy; metastasis; priority journal; spindle cell; Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Breast Neoplasms, Male; Carcinoma, Adenosquamous; Carcinoma, Ductal, Breast; Carcinosarcoma; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Epirubicin; Estrogens; Female; Fluorouracil; Humans; Inflammation; Lymphatic Metastasis; Male; Mastectomy; Metaplasia; Middle Aged; Neoplasm Metastasis; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Progesterone; Receptors, Estrogen; Receptors, Progesterone; Retrospective Studies; Taiwan; Treatment Outcome; Tumor Markers, Biological
Type
journal article